Pingjiao Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pingjiao Chen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Changxing Li
Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Kang Zeng
Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Qi Wang
Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications - Chao Yang
Dermatology Hospital Southern Medical University Guangzhou China
1 shared publication - Chenmei Liu
Department of Dermatology Dermatology Hospital of Southern Medical University Guangzhou Guangdong China
1 shared publication - Hongyan Lu
Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
1 shared publication
Latest Publications
- 28 January 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (7) , 1313-1317.e8
Variants in the Gene Encoding Filaggrin Cause Autosomal-Dominant Symmetrical Acral Keratoderma
- 28 January 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (7) , 1313-1317.e8
Variants in the Gene Encoding Filaggrin Cause Autosomal-Dominant Symmetrical Acral Keratoderma
- 19 August 2020
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 33 (9) , 1219-1224
A novel GNAS mutation inherited from probable maternal mosaicism causes two siblings with pseudohypoparathyroidism type 1A
Objectives: Objectives Pseudohypoparathyroidism type 1A (PHP1A) is caused by maternal inheritance of GNAS mutations. It is characterized by the resistance to several hormones, primarily the parathyroid hormone (PTH), and the features of Albright’s hereditary osteodystrophy. Case presentation: Here, we present a family comprised two affected brothers with PHP1A and identify a novel mutation (c.277C>T) in the GNAS gene. The siblings developed a slightly different presentation in the same clinical condition. Although both patients presented with PTH resistance, which is the hallmark of PHP, the proband showed the thyroid-stimulating hormone resistance with the progression of heterotopic ossification from skin and subcutaneous tissue into deep connective tissue, while the younger brother with normocalcemia did not show the resistance to other hormones. The patients may inherit the mutation from their mother who presumably carries the mutation as a mosaicism. Conclusions: Our case highlights the significance of considering mosaicism as an explanation for apparent de novo cases of pseudohypoparathyroidism.
- 19 August 2020
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 33 (9) , 1219-1224
A novel GNAS mutation inherited from probable maternal mosaicism causes two siblings with pseudohypoparathyroidism type 1A
Objectives: Objectives Pseudohypoparathyroidism type 1A (PHP1A) is caused by maternal inheritance of GNAS mutations. It is characterized by the resistance to several hormones, primarily the parathyroid hormone (PTH), and the features of Albright’s hereditary osteodystrophy. Case presentation: Here, we present a family comprised two affected brothers with PHP1A and identify a novel mutation (c.277C>T) in the GNAS gene. The siblings developed a slightly different presentation in the same clinical condition. Although both patients presented with PTH resistance, which is the hallmark of PHP, the proband showed the thyroid-stimulating hormone resistance with the progression of heterotopic ossification from skin and subcutaneous tissue into deep connective tissue, while the younger brother with normocalcemia did not show the resistance to other hormones. The patients may inherit the mutation from their mother who presumably carries the mutation as a mosaicism. Conclusions: Our case highlights the significance of considering mosaicism as an explanation for apparent de novo cases of pseudohypoparathyroidism.